Committee on Quality
Committee Roster
Chair
Adam Cuker, MD, MS
('25)
Appointed Members
Gregory Abel, MD, MPH
('26)
Donald
M. Arnold, MD
('27)
Amy Billett, MD
('27)
Adam
F. Binder, MD
('26)
Stella Chou, MD
('27)
Rachel
J. Cook, MD
('25)
Reem Karmali, MD, MSc
('25)
Michael
K. Keng, MD
('26)
Thomas Knight, MD
('25)
Robert
I. Liem, MD
('27)
Camila Masias, MD, MPH
('27)
Matthew
J. Matasar, MD, MS
('25)
Jori May, MD
('24)
Cindy Neunert, MD
('26)
Jacquelyn
M. Powers, MD
('24)
Rachel Rosovsky, MD
('24)
Surbhi Shah, MD
('26)
Ex Officio Members
Belinda Avalos, MD
('25)
-
Mohandas Narla, DSc
('24)
-
Robert Negrin, MD
('26)
-
Liaisons
Siobhan Branfield, MD, PhD
('25)
-
Matthew Cheung, MD, MSc
('24)
-
Jean M.
M. Connors, MD
('27)
-
Monique Hartley-Brown, MD
('25)
-
Ming
Y. Lim, MBBChir
('25)
-
Kah Poh (Melissa) Loh, MD
('27)
-
Heather Male, MD
('26)
-
Chadi Nabhan, MD, MBA
('24)
-
Jennifer Rothman, MD
('26)
-
Jamile
M. Shammo, MD
('24)
-
Michael
T. Tees, MD, MPH
('28)
-
Pallawi Torka, MD
('25)
-
Staff Liaison
Dzܲ
Committee Mandate
The Committee on Quality promotes the highest quality care of patients with hematologic diseases and is responsible for overseeing and implementing the ASH Executive Committee-approved quality initiative, including but not limited to the development of clinical practice guidelines; tools and resources to aid dissemination and implementation of the guidelines including pocket guides, teaching slide sets, clinical pathways, patient versions, educational modules, and adaptation efforts; quality performance measures; quality toolkits; educational programming during the ASH annual meeting; promotion of research in quality and health care outcomes among hematologist and others; response to policy-related efforts and representing the society at quality forums and meetings. Members of this committee may not be employees or owners of Ineligible Companies, as defined by the Accreditation Council for Continuing Medical ѻý. The Committee on Quality oversees the work of the following: 1. The Guideline Oversight Subcommittee oversees the development of ASH clinical guidelines. 2. The Quality Measure Oversight Subcommittee coordinates the identification, prioritization, development, and management of a set of quality measures which aim to improve the quality, effectiveness, and efficiency of hematology care that patients receive. 3. The Subcommittee on Dissemination and Implementation Science establishes and coordinates the identification, prioritization, and management of dissemination and implementation activities for ASH guidelines and other related quality efforts. 4. The Subcommittee on Quality Improvement ѻý and Training establishes and coordinates the identification, prioritization, development, and management of resources and programs which aim to improve the quality improvement education and training available to practicing hematologists. 5. The Subcommittee on Stewardship and Systems-based Hematology coordinates the development of sessions, programs, educational materials, publications, and other activities designed to further ASH’s goal of encouraging stewardship of resources, enhancing patient safety, and promoting the concept of “systems-based hematology” as a viable career path for hematologists. To allow for continual crosscutting dialogue with other standing committees, the Committee on Quality structure includes liaison positions from the following committees: The chairs of the Guideline Oversight Subcommittee; Quality Measure Oversight Subcommittee; Subcommittee on Dissemination and Implementation Science; Subcommittee on Quality Improvement ѻý and Training; and Subcommittee on Stewardship and Systems-based Hematology (unless an appointed member of the committee) serve as liaison members of the Committee on Quality. Members of the Committee on Quality are required to participate in occasional meetings at ASH Headquarters, monthly conference calls, and workgroups as needed, and are called upon to respond to written requests related to the quality agenda. The Chair of the Committee on Quality serves as a liaison member of the Media Experts Subcommittee; Program Committee; Quality Measure Oversight Subcommittee; and Subcommittee on Systems-Based Hematology and is expected to attend the meetings of those committees. The chair also serves as an ex-officio (non-voting) member of the Guideline Oversight Subcommittee. A member of the Committee on Quality serves as a liaison member of the Reimbursement Subcommittee and is expected to attend the meetings of that committee.
...